Preventing cervical cancer in East Africa
Project 1: A Public Health Approach to Cervical Cancer Prevention in East Africa
This project tries community-based vaccination, screening, and follow-up care to prevent cervical cancer among women in East Africa.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11416274 on NIH RePORTER |
What this research studies
Researchers are partnering with clinics and communities across East Africa to increase HPV vaccination and regular cervical screening using methods such as HPV testing, visual exams, and mobile clinics. They will try different ways to deliver care—like outreach education, school- or clinic-based vaccination, and rapid 'screen-and-treat' approaches—and track how many women complete screening and receive timely treatment. The team will follow health records and may collect samples to monitor HPV infections and precancerous changes while training local health workers to provide sustainable services. Findings will help identify practical ways to reach more women and catch disease earlier.
Who could benefit from this research
Good fit: Ideal participants are women in participating East African communities who are eligible for HPV vaccination or cervical cancer screening and willing to attend local clinics or outreach events.
Not a fit: People who live outside the participating regions, are already diagnosed with advanced cervical cancer, or cannot access participating clinics may not directly benefit.
Why it matters
Potential benefit: If successful, this work could lower cervical cancer cases and deaths by improving vaccination, early detection, and access to treatment in East Africa.
How similar studies have performed: HPV vaccination and screen-and-treat programs have reduced cervical precancers and cancers in several countries, but this project adapts and scales those approaches specifically for East African settings.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.